{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:48:39Z","timestamp":1769125719439,"version":"3.49.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"\n Introduction<\/jats:title>\n Oral anticoagulants (OACs) are essential for managing thromboembolic events and cardiovascular conditions. However, they carry a significant bleeding risk. Pharmacists play a critical role in ensuring the safe and effective use of these medications. Within Gulf Cooperation Council (GCC) countries, hospital pharmacists are involved in managing OACs. However, region specific data on their knowledge and practices remain limited.<\/jats:p>\n <\/jats:sec>\n \n Aim<\/jats:title>\n This review analysed existing literature regarding hospital pharmacists\u2019 knowledge and practices in OACs dispensing and counselling within the GCC countries.<\/jats:p>\n <\/jats:sec>\n \n Methodology<\/jats:title>\n A literature search was conducted in Scopus, Web of Science, PubMed and PsycINFO. Articles that explored the hospital pharmacist\u2019s knowledge and practices regarding OACs were included. There were no restrictions on study design, publication date, or language. Searches were undertaken on February 1, 2025 then re-run on October 28, 2025, following PRISMA-ScR and JBI guidelines.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Findings revealed gaps in pharmacists\u2019 knowledge and practices regarding OACs management. Out of 75 articles identified, seven met inclusion criteria, representing studies from Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates (UAE). All were cross-sectional and utilized validated questionnaires. A study from Saudi Arabia and another from the UAE reported gaps in warfarin knowledge. Counselling practices were suboptimal in both studies. One study further identified insufficient knowledge of warfarin interactions. Beyond warfarin, one study reported deficiencies in rivaroxaban knowledge and counselling, while another found moderate awareness of direct oral anticoagulants (DOACs) (mean score 41.6%\u202f\u00b1\u202f26%). Another study reported inadequate practice in OACs dispensing and monitoring, and another study found greater pharmacists\u2019 confidence in counselling on vitamin K antagonists (VKAs) (67%) than on DOACs (49%).<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n Findings highlight inadequate knowledge and practice among pharmacists regarding OACs. Although all studies included community pharmacists and other healthcare providers, none focused exclusively on hospital pharmacists, who are more directly involved in OAC management in the GCC. All studies relied solely on self-reported data, increasing bias. Most studies originated from Qatar, Saudi Arabia, and the UAE, reducing generalizability. Nevertheless, addressing knowledge gaps could improve hospital pharmacists\u2019 practice on OACs management, improving patient safety, and optimising therapeutic outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1743611","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:54:06Z","timestamp":1769064846000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the knowledge level and practices of hospital pharmacists in management of oral anticoagulants in Gulf Cooperation Council countries: a scoping review of literature"],"prefix":"10.3389","volume":"14","author":[{"given":"Abdulaziz","family":"Alanazi","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Reading","place":["Reading, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atta Abbas","family":"Naqvi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Reading","place":["Reading, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh","family":"Patel","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King's College London","place":["London, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Tamagnini","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Reading","place":["Reading, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"ref1","volume-title":"Anticoagulation - oral: Background information [internet]","year":""},{"key":"ref2","volume-title":"World Health Organisation: Medication safety in high-risk situations","year":""},{"key":"ref3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.sapharm.2025.02.009","article-title":"Outcomes of pharmacist-led patient education on oral anticoagulant therapy: a scoping review","volume":"21","author":"Omer","year":"2025","journal-title":"Res Soc Adm Pharm"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-22602-6","volume-title":"Anticoagulation management: A guidebook for pharmacists","author":"Rose","year":"2015"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40545-022-00486-0","article-title":"Pharmacist management of atrial fibrillation in UK primary care: a qualitative study","volume":"15","author":"Al-Arkee","year":"2022","journal-title":"J. Pharmaceutical Policy Practice"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1177\/1060028017721241","article-title":"Quality of pharmacist-managed anticoagulation therapy in long-term ambulatory settings: a systematic review","volume":"51","author":"Manzoor","year":"2017","journal-title":"Ann Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jemermed.2017.06.008","article-title":"Impact of discharge anticoagulation education by emergency department pharmacists at a tertiary Academic Medical Center","volume":"53","author":"Zdyb","year":"2017","journal-title":"J Emerg Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/ehjqcco\/qcae045","article-title":"The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis","volume":"10","author":"Kefale","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref9","volume-title":"Stroke - level 3 cause","year":"2021"},{"key":"ref10","year":"2021"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1093\/eurheartj\/ehac252","article-title":"Global impact of deep vein thrombosis awareness month: challenges and future recommendations","volume":"43","author":"Malhotra","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"p2567","DOI":"10.1136\/bmj.p2567","article-title":"NHS England drive sees almost half a million people started on anticoagulant drugs","volume":"383","author":"Mahase","year":"2023","journal-title":"BMJ"},{"key":"ref13","first-page":"433","article-title":"Trends in Oral anticoagulant use and individual expenditures across the United States from 2014 to 2020","volume-title":"Am J Cardiovasc Drugs","author":"Alkhezi","year":""},{"key":"ref14","doi-asserted-by":"crossref","first-page":"235101","DOI":"10.1155\/2015\/235101","article-title":"Prevalence of cardiovascular disease and associated risk factors among adult population in the Gulf region: a systematic review","volume":"2015","author":"Aljefree","year":"2015","journal-title":"Advances Public Health"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jtumed.2024.07.009","article-title":"Burden of non-communicable diseases in health Council of Gulf Cooperation (GCC) countries","volume":"19","author":"Alqadasi","year":"2024","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"ref16","volume-title":"Saudi Arabia: Country overview","year":"2025"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12872-024-03845-8","article-title":"A national perspective on cardiovascular diseases in Saudi Arabia","volume":"24","author":"Alqahtani","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"ref18","first-page":"e2024038","article-title":"Clinical care pathway and management of major bleeding associated with nonvitamin K antagonist oral anticoagulants: a modified Delphi consensus from Saudi Arabia and UAE","volume-title":"Mediterr. J. Hematol. Infect. Dis.","author":"Al Raizah","year":"2024"},{"key":"ref19","article-title":"Anti-coagulants - GCC | Statista market forecast","year":""},{"key":"ref20","first-page":"315","article-title":"Healthcare quality from the perspective of patients in gulf cooperation council countries: a systematic literature review","volume-title":"Healthcare","author":"Alsubahi","year":"2024"},{"key":"ref21","first-page":"1510401","volume-title":"Front. Public Health","author":"AlRuthia","year":"2025"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.3390\/healthcare12242544","article-title":"Healthcare financing in Saudi Arabia: a comprehensive review","volume":"12","author":"Nair","year":"2024","journal-title":"Healthcare"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1007\/978-3-030-36811-1_194","article-title":"Oral anticoagulant therapy in the Arab world","volume-title":"Handbook of healthcare in the Arab world","author":"Abdeladim","year":"2021"},{"key":"ref24","first-page":"40","article-title":"Best strategies for patient education about anticoagulation with warfarin: a systematic review","volume-title":"BMC Health Serv. Res.","author":"Wofford","year":"2008"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s11096-017-0529-0","article-title":"How prepared are pharmacists to support atrial fibrillation patients in adhering to newly prescribed oral anticoagulants?","volume":"39","author":"Hamedi","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12959-015-0046-0","article-title":"Implementation of non-vitamin K antagonist oral anticoagulants in daily practice: the need for comprehensive education for professionals and patients","volume":"13","author":"Heidbuchel","year":"2015","journal-title":"Thromb J"},{"key":"ref27","article-title":"Survey of knowledge and attitude of pharmacists about direct Oral anticoagulants: a cross-sectional study","volume":"9","author":"Zahra","year":"2021","journal-title":"J. Pharmaceutical Care"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11096-023-01555-3","article-title":"Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists\u2019 views and experiences","volume":"45","author":"Al Rowily","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"101952","DOI":"10.1016\/j.jsps.2024.101952","article-title":"Pharmacy practice in hospital settings in GCC countries: pharmacists\u2019 medication therapy monitoring activities","volume":"32","author":"Al-jedai","year":"2024","journal-title":"Saudi Pharmaceutical J."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"ref31","article-title":"Chapter 11: scoping reviews (2020 version)","volume-title":"JBI manual for evidence synthesis","author":"Peters","year":"2020"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan \u2014 a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/1874192401206010072","article-title":"A prospective study on the use of warfarin in the United Arab Emirates","volume":"6","author":"Shehab","year":"2012","journal-title":"Open Cardiovascular Med. J."},{"key":"ref34","first-page":"2883","article-title":"Healthcare professionals and undergraduate students' knowledge toward drug-food interactions in the eastern region of Saudi Arabia","volume-title":"J. Multidiscip. Healthc.","author":"Alhubail","year":"2023"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e0203033","DOI":"10.1371\/journal.pone.0203033","article-title":"Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait","volume":"13","author":"Albassam","year":"2018","journal-title":"PLoS One"},{"key":"ref36","first-page":"289","article-title":"Pharmacists' warfarin therapy knowledge and counseling practices in the Eastern Province, Saudi Arabia: a cross-sectional study","author":"Mohamed","year":"2020"},{"key":"ref37","first-page":"319","article-title":"Assessment of knowledge and counseling practice of warfarin among pharmacists in UAE: a cross-sectional study","volume-title":"J Thromb Thrombolysis","author":"Alkherat","year":"2018"},{"key":"ref38","article-title":"Evaluation of knowledge of health care professionals on warfarin interactions with drug and herb medicinal in Central Saudi Arabia","author":"Al-Arifi","year":""},{"key":"ref39","first-page":"414","article-title":"Hospital pharmacist's Management of Patients on rivaroxaban in Saudi Arabia: a cross sectional survey","volume":"39","author":"Mansy","year":"2020","journal-title":"Lat Am J Pharm"},{"key":"ref40","first-page":"1076029620933946","article-title":"Assessing pharmacists\u2019 knowledge and attitude toward the direct Oral anticoagulants in Qatar","volume-title":"Clinical and Applied Thrombosis\/Hemostasis","author":"El-Bardissy","year":"2020"},{"key":"ref41","first-page":"1282","article-title":"Pharmacists' confidence when providing pharmaceutical care on anticoagulants, a multinational survey","volume-title":"Int. J. Clin. Pharm","author":"Papastergiou","year":"2017"},{"key":"ref42","first-page":"1021","article-title":"Pharmacy practice in hospital settings in GCC countries: prescribing and transcribing","volume-title":"Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society","author":"Al-Jedai","year":"2021"},{"key":"ref43","volume-title":"Xarelto (rivaroxaban): EPAR \u2013 Medicine overview [internet]","year":""},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e0257798","DOI":"10.1371\/journal.pone.0257798","article-title":"Barriers and facilitators for optimizing oral anticoagulant management: perspectives of patients, caregivers, and providers","volume":"16","author":"Holbrook","year":"2021","journal-title":"PLoS One"},{"key":"ref45","first-page":"4215","article-title":"Prevalence of Dyslipidemia and its determinants among the adult population of the Jazan region","volume-title":"Int. J. Gen. Med.","author":"Ghazwani","year":"2013"},{"key":"ref46","first-page":"4033","article-title":"Prevalence and associated factors of Dyslipidemia among adults with type 2 diabetes mellitus in Saudi Arabia","volume-title":"Diabetes Metab Syndr Obes: Targets Ther","author":"Alzaheb","year":""},{"key":"ref47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/07315724.2000.10718944","article-title":"Assessment of healthcare professionals\u2019 knowledge about warfarin-vitamin K drug-nutrient interactions","volume":"19","author":"Couris","year":"2000","journal-title":"J Am Coll Nutr"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/j.2055-2335.2009.tb00475.x","article-title":"Complementary medicines: hospital pharmacists' attitude, knowledge and information seeking behaviour","volume":"39","author":"Brown","year":"2009","journal-title":"J Pharm Pract Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/pharmacy12060172","article-title":"Evaluating pharmacists\u2019 knowledge of food\u2013drug interactions in Croatia: identifying gaps and opportunities","volume":"12","author":"Buki\u0107","year":"2024","journal-title":"Pharmacy"},{"key":"ref50","volume-title":"Assessment of training needs pharmacists on anti-thrombotic Therapy2016","author":"Caldeira","year":"2016"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.sapharm.2021.01.008","article-title":"Auditing the scope of antithrombotic care in iPACT (international pharmacists for anticoagulation care taskforce) represented countries","volume":"17","author":"Alves da Costa","year":"2021","journal-title":"Res Soc Adm Pharm"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"542","DOI":"10.2146\/ajhp090596","article-title":"ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education\u20142009","volume":"67","author":"Pedersen","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40545-021-00377-w","article-title":"How confident are pharmacists in providing pharmaceutical care on anticoagulants? A cross-sectional, self-administered questionnaire study in Borneo, Malaysia","volume":"14","author":"Tan","year":"2021","journal-title":"J. Pharmaceutical Policy Practice."},{"key":"ref54","article-title":"Assessment of pharmacists\u2019 confidence when consulting patients on anticoagulants: a cross-sectional study in Iran","volume":"10","author":"Elliyeh","year":"2022","journal-title":"J. Pharmaceutical Care"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.36290\/csf.2024.004","article-title":"Direct oral anticoagulants from the perspective of Czech pharmacists - opinions, attitudes, confidence, and patient education during dispensing in a pharmacy","volume":"73","author":"Dvorackova","year":"2024","journal-title":"Czech Slovak Pharmacy"},{"key":"ref56","volume-title":"Protocol for medicine optimisation reviews for direct acting Oral anticoagulants (DOACs) in atrial fibrillation","year":"2025"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archinte.166.9.955","article-title":"Clinical pharmacists and inpatient medical care: a systematic review","volume":"166","author":"Kaboli","year":"2006","journal-title":"Arch Intern Med"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/MLR.0b013e3181e57962","article-title":"US pharmacists' effect as team members on patient care: systematic review and Meta-analyses","volume":"48","author":"Chisholm-Burns","year":"2010","journal-title":"Med Care"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13584-019-0285-9","article-title":"Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program","volume":"8","author":"Perlman","year":"2019","journal-title":"Isr J Health Policy Res"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/08971900231166555","article-title":"The impact of clinical pharmacy services on direct Oral anticoagulant medication selection and dosing in the ambulatory care setting","volume":"37","author":"Yates","year":"2023","journal-title":"J Pharm Pract"},{"key":"ref61","doi-asserted-by":"crossref","DOI":"10.4021\/jocmr2010.03.283w","article-title":"Inpatient Oral anticoagulation management by clinical pharmacists: safety and cost effectiveness","author":"Hosmane","year":""},{"key":"ref62","doi-asserted-by":"publisher","first-page":"102517","DOI":"10.1016\/j.cpcardiol.2024.102517","article-title":"Role of clinical pharmacy anticoagulation service on apixaban prescribing appropriateness in atrial fibrillation in Saudi Arabia","volume":"49","author":"Emad","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.3390\/jcm12123887","article-title":"Impact of clinical pharmacist running anticoagulation Clinic in Saudi Arabia","volume":"12","author":"Alshaiban","year":"2023","journal-title":"J Clin Med"},{"key":"ref64","volume-title":"Saudi Commission for Health Specialties. Vitamin K antagonist oral anticoagulants clinical pathway [internet]","year":""},{"key":"ref65","volume-title":"Saudi Commission for Health Specialties. Direct oral anticoagulants (DOACs) clinical pathway [internet]","year":"2020"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/ijnpnd.ijnpnd_147_25","article-title":"Evaluation of clinical pharmacy services and pharmacist authority across healthcare sectors in Saudi Arabia","volume":"15","author":"Alsohaim","year":"2025","journal-title":"Int. J. Nutr. Pharmacol. Neurol. Dis."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1743611\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:54:11Z","timestamp":1769064851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1743611\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":66,"alternative-id":["10.3389\/fpubh.2026.1743611"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1743611","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"article-number":"1743611"}}